685 related articles for article (PubMed ID: 22014950)
21. Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?
Aznar MC; Maraldo MV; Schut DA; Lundemann M; Brodin NP; Vogelius IR; Berthelsen AK; Specht L; Petersen PM
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):169-74. PubMed ID: 25754634
[TBL] [Abstract][Full Text] [Related]
22. Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment?
Maraldo MV; Brodin P; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):297-303. PubMed ID: 23910709
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
[TBL] [Abstract][Full Text] [Related]
24. The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma.
Jørgensen AY; Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Rosenschöld PM; Petersen PM; Specht L
Acta Oncol; 2013 Oct; 52(7):1559-65. PubMed ID: 24047340
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
[TBL] [Abstract][Full Text] [Related]
26. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
27. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
[TBL] [Abstract][Full Text] [Related]
28. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
Hoppe BS; Flampouri S; Zaiden R; Slayton W; Sandler E; Ozdemir S; Dang NH; Lynch JW; Li Z; Morris CG; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1053-1059. PubMed ID: 24928256
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma.
Sakanaka K; Mizowaki T; Hiraoka M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e273-80. PubMed ID: 21640515
[TBL] [Abstract][Full Text] [Related]
30. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
Nichols RC; Huh SN; Henderson RH; Mendenhall NP; Flampouri S; Li Z; D'Agostino HJ; Cury JD; Pham DC; Hoppe BS
Clin Lung Cancer; 2011 Jul; 12(4):252-7. PubMed ID: 21726825
[TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning.
Lee YK; Brooks CJ; Bedford JL; Warrington AP; Saran FH
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1006-12. PubMed ID: 21345612
[TBL] [Abstract][Full Text] [Related]
32. Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.
Nieder C; Schill S; Kneschaurek P; Molls M
Radiother Oncol; 2007 Mar; 82(3):301-7. PubMed ID: 17156873
[TBL] [Abstract][Full Text] [Related]
33. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
34. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
35. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
36. Optimized dose coverage of regional lymph nodes in breast cancer: the role of intensity-modulated radiotherapy.
Dogan N; Cuttino L; Lloyd R; Bump EA; Arthur DW
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1238-50. PubMed ID: 17512134
[TBL] [Abstract][Full Text] [Related]
37. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?
Ares C; Khan S; Macartain AM; Heuberger J; Goitein G; Gruber G; Lutters G; Hug EB; Bodis S; Lomax AJ
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):685-97. PubMed ID: 19615828
[TBL] [Abstract][Full Text] [Related]
38. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
[TBL] [Abstract][Full Text] [Related]
39. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
